DOMINICI, Massimo
 Distribuzione geografica
Continente #
NA - Nord America 23.765
EU - Europa 12.763
AS - Asia 3.983
SA - Sud America 56
OC - Oceania 50
AF - Africa 44
Continente sconosciuto - Info sul continente non disponibili 23
Totale 40.684
Nazione #
US - Stati Uniti d'America 23.564
IT - Italia 3.891
GB - Regno Unito 3.659
SE - Svezia 1.442
CN - Cina 1.269
DE - Germania 1.185
SG - Singapore 815
HK - Hong Kong 733
UA - Ucraina 495
IE - Irlanda 483
TR - Turchia 474
FI - Finlandia 439
BG - Bulgaria 271
FR - Francia 253
CA - Canada 178
ID - Indonesia 167
IN - India 135
BE - Belgio 130
JP - Giappone 110
VN - Vietnam 73
RO - Romania 59
CZ - Repubblica Ceca 57
NL - Olanda 56
RU - Federazione Russa 56
LT - Lituania 54
AU - Australia 49
IR - Iran 43
ES - Italia 41
MY - Malesia 38
CH - Svizzera 35
TW - Taiwan 28
NO - Norvegia 27
KR - Corea 24
PK - Pakistan 24
BR - Brasile 23
PL - Polonia 23
AL - Albania 21
AT - Austria 18
EU - Europa 16
CL - Cile 15
IL - Israele 13
EG - Egitto 11
PT - Portogallo 11
BZ - Belize 10
PH - Filippine 9
DK - Danimarca 8
MX - Messico 8
GR - Grecia 7
RS - Serbia 7
A2 - ???statistics.table.value.countryCode.A2??? 6
AR - Argentina 6
SA - Arabia Saudita 6
DZ - Algeria 5
HR - Croazia 5
KE - Kenya 5
MT - Malta 5
ZA - Sudafrica 5
CR - Costa Rica 4
HU - Ungheria 4
MA - Marocco 4
MK - Macedonia 4
PE - Perù 4
SI - Slovenia 4
TH - Thailandia 4
BD - Bangladesh 3
CO - Colombia 3
EE - Estonia 3
KZ - Kazakistan 3
LA - Repubblica Popolare Democratica del Laos 3
MD - Moldavia 3
NG - Nigeria 3
OM - Oman 3
UG - Uganda 3
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
DJ - Gibuti 2
ET - Etiopia 2
GH - Ghana 2
SY - Repubblica araba siriana 2
VE - Venezuela 2
AN - Antille olandesi 1
AP - ???statistics.table.value.countryCode.AP??? 1
BW - Botswana 1
BY - Bielorussia 1
EC - Ecuador 1
IS - Islanda 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
MO - Macao, regione amministrativa speciale della Cina 1
MV - Maldive 1
NZ - Nuova Zelanda 1
QA - Qatar 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 40.684
Città #
Fairfield 3.780
Southend 2.741
Chandler 2.281
Woodbridge 1.976
Ashburn 1.927
Houston 1.529
Seattle 1.326
Cambridge 1.172
Wilmington 1.146
Ann Arbor 1.111
Nyköping 979
Jacksonville 963
Dearborn 859
Hong Kong 710
Singapore 593
Modena 506
Dublin 454
San Diego 417
Beijing 390
New York 352
Princeton 306
Izmir 303
Helsinki 279
Sofia 271
Bologna 267
Milan 262
Munich 234
Eugene 200
Jakarta 160
London 151
Shanghai 133
Redwood City 130
Parma 121
Des Moines 120
Rome 120
Falls Church 119
Bremen 114
Brussels 109
Mcallen 109
Fremont 107
Boardman 106
Montréal 103
Reggio Emilia 78
Frankfurt am Main 71
Tokyo 68
Dong Ket 60
Phoenix 59
Grafing 56
Norwalk 56
Brno 47
San Giuliano Milanese 46
Guangzhou 42
Chicago 37
San Mateo 36
Verona 36
Enfield 33
Nanjing 33
Toronto 33
Ravenna 32
Dallas 31
Padova 29
Hefei 28
Chiswick 27
Hounslow 27
Kilburn 27
Los Angeles 26
Bari 24
Napoli 24
Palermo 24
Amsterdam 23
Timisoara 23
Vicenza 23
Casalecchio Di Reno 22
Dongguan 22
Naples 20
Turin 20
Kunming 18
Mountain View 18
Ottawa 18
Paris 18
Rimini 18
Roncoferraro 18
Pavia 17
Genoa 16
Bergen 15
Ferrara 15
Kuala Lumpur 15
Lahore 15
Philadelphia 15
Reggio Nell'emilia 15
San Jose 15
Augusta 14
Leawood 14
Piacenza 14
Segrate 14
Ardabil 13
Castelvetrano 13
Nanchang 13
Prescot 13
Tirana 13
Totale 30.646
Nome #
Dynamic cultivation of mesenchymal stem cell aggregates 586
Impressive response to dose-dense chemotherapy in a patient with NUT midline carcinoma 360
The puzzling situation of hospital exemption for advanced therapy medicinal products in Europe and stakeholders' concerns 311
CD271 Mediates Stem Cells to Early Progeny Transition in Human Epidermis 303
MSC-delivered soluble TRAIl and paclitaxel as novel combinatory treatment for pancreatic adenocarcinoma 292
GD2 expression in breast cancer. 291
Autologous Porcine Bone Marrow Mesenchymal Cells for Reconstruction of a Resorbed Alveolar Bone: A Preclinical Model in Mini-Pigs 275
Adipose stromal/stem cells assist fat transplantation reducing necrosis and increasing graft performance. 270
Impact of time to surgery after neoadjuvant chemotherapy in operable breast cancer patients 268
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement 266
Microglia are less pro-inflammatory than myeloid infiltrates in the hippocampus of mice exposed to status epilepticus 264
Rigenerand srl - Spin off Università di Modena e Reggio Emilia 261
PCR con primer degenerati non evidenzia sequenze virali di HHV-8 ne di una sua variante in cellule stromali midollari di pazienti affetti da gammopatie monoclonali 258
Soluble TRAIL Armed Human MSC As Gene Therapy For Pancreatic Cancer 257
A Novel 3D In Vitro Platform for Pre-Clinical Investigations in Drug Testing, Gene Therapy, and Immuno-oncology. 257
Targeting GD2-positive glioblastoma by chimeric antigen receptor empowered mesenchymal progenitors 255
Inducible Caspase9-mediated suicide gene for MSC-based cancer gene therapy 250
Delayed marrow infusion in mice enhances hematopoietic and osteopoietic engraftment by facilitating transient expansion of the osteoblastic niche 249
A novel anti-GD2/4-1BB chimeric antigen receptor triggers neuroblastoma cell killing 247
Mesenchymal stem/stromal cells as a delivery platform in cell and gene therapies 246
A novel function for amniotic fluid: original or authentic? 239
Altered pH gradient at the plasma membrane of osteosarcoma cells is a key mechanism of drug resistance 238
cGMP-compliant transportation conditions for a prompt therapeutic use of marrow mesenchymal stromal/stem cells 237
In vitro differentiation of human amniotic epithelial cells into insulin-producing 3D spheroids 236
SOLUBLE TRAIL-ARMED HUMAN AD-MSC AS NOVEL CELL THERAPY APPROACH FOR PANCREATIC DUCTAL ADENOCARCINOMA 223
Isolation, characterization, and transduction of endometrial decidual tissue multipotent mesenchymal stromal/stem cells from menstrual blood 219
Tumor Stroma Manipulation By MSC 217
Adipose-derived mesenchymal stem cells as stable source of tumor necrosis factor-related apoptosis-inducing ligand delivery for cancer therapy 215
Identification of a murine CD45-F4/80lo HSC-derived marrow endosteal cell associated with donor stem cell engraftment 211
Le Cellule Staminali Mesenchimali: Aspetti Biologici ed Approcci Terapeutici 210
MSC and Tumors: Homing, Differentiation and Secretion Influence The Therapeutic Potentials 208
An alternative approach to investigate biofilm in medical devices: A feasibility study 208
Mesenchymal progenitors aging highlights a mir-196 switch targeting HOXB7 as master regulator of proliferation and osteogenesis 206
Modulation of Mutational Landscape in HER2-Positive Breast Cancer after Neoadjuvant Chemotherapy 205
Transplanted murine long-term repopulating hematopoietic cells can differentiate to osteoblasts in the marrow stem cell niche 204
Potency biomarker signature genes from multiparametric osteogenesis assays: Will cGMP human bone marrow mesenchymal stromal cells make bone? 204
Nivolumab-Induced Impressive Response of Refractory Pulmonary Sarcomatoid Carcinoma with Brain Metastasis 203
Suppression of invasion and metastasis of triple-negative breast cancer lines by pharmacological or genetic inhibition of slug activity 202
Restoration and reversible expansion of the osteoblastic hematopoietic stem cell niche after marrow radioablation 200
Mesenchymal progenitors expressing TRAIL induce apoptosis in sarcomas 198
Blocking tumor-educated MSC paracrine activity halts osteosarcoma progression 197
Human mesenchymal stem cell combined with a new strontium-enriched bioactive glass: An ex-vivo model for Bone Regeneration 197
Phase I study of intraperitoneal MHC unrestricted adoptive cell therapy with TALL-104 cells in patients with peritoneal carcinosis 195
Surrounding pancreatic adenocarcinoma by killer mesenchymal stromal/stem cells 194
Predictors of human epidermal growth factor receptor 2 fluorescence in-situ hybridisation amplification in immunohistochemistry score 2+ infiltrating breast cancer: a single institution analysis. 193
0.1 grams of sub-cutaneous adipose tissue (SCAT) as source of adult multipotent mesenchymal stromal cells (MSC) for cell-based therapies 193
METHOD FOR PRODUCTION OF ANTI-TUMOR TRAIL PROTEIN 192
Correlating tumor-infiltrating lymphocytes and lung cancer stem cells: a cross-sectional study. 189
Osteopoietic engraftment after bone marrow transplantation: Effect of inbred strain of mice 188
Transportation conditions for prompt use of Ex Vivo expanded and freshly harvested clinical-grade bone marrow mesenchymal stromal/stem cells for bone regeneration 188
Interstitial Lung Disease in Abemaciclib-treated Patients during SARS-CoV-2 Pandemic: A Case Series. 187
Cytokine-Induced Osteopoietic Differentiation of Transplanted Marrow Cells 186
GMP-manufactured density gradient media for optimized mesenchymal stromal/stem cell isolation and expansion. 186
Clinical Prognosticators in Patients Treated with CDK 4/6 Inhibitors for Hormone Receptors Positive Advanced Breast Cancer 184
Part 1: Defining unproven cellular therapies 182
Cancer stem-neuroendocrine cells in an atypical carcinoid case report. 182
International society for cellular therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials 179
Cancer Stem-Like Cells in a Case of an Inflammatory Myofibroblastic Tumor of the Lung. 179
Circulating mucosal-associated invariant T cells identify patients responding to anti-PD-1 therapy 178
Overall survival in patients with lung adenocarcinoma harboring "niche" mutations: an observational study 177
Bone marrow mesenchymal cells: biological properties and clinical applications. 176
Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: A joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT) 175
Mineralization by mesenchymal stromal cells is variously modulated depending on commercial platelet lysate preparations 175
Label-free toxicology screening of primary human mesenchymal cells and iPS-derived neurons 175
Resistance to neoplastic transformation of ex-vivo expanded human mesenchymal stromal cells after exposure to supramaximal physical and chemical stress 174
Discordance in receptor status between primary and recurrent breast cancer has a prognostic impact: a single Institution analysis 174
Cell therapies for pancreatic beta-cell replenishment. 173
Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients 173
Feasibility and safety of treating non-unions in tibia, femur and humerus with autologous, expanded, bone marrow-derived mesenchymal stromal cells associated with biphasic calcium phosphate biomaterials in a multicentric, non-comparative trial 171
Rare breast cancer subtypes: Histological, molecular, and clinical peculiarities 171
Body composition and inflammation impact in non-small cell lung cancer patients treated by first-line immunotherapy 171
The Survey on Cellular and Engineered Tissue Therapies in Europe in 2013 170
Arming Mesenchymal Stromal/Stem Cells Against Cancer: Has the Time Come? 170
Lack of confirmation of an association between HTLV-I infection and myelodysplastic syndrome 166
Human Herpes simplex 1 virus infection of endometrial decidual tissue-derived MSC alters HLA-G expression and immunosuppressive functions 166
The phenotypes of microglia and macrophages during epileptogenesis 166
Multicentre validation of an immune-inflammation-based nomogram to predict survival in western resectable gastroesophageal adenocarcinoma: The NOMOGAST 166
Mesenchymal stromal cells for cutaneous wound healing in a rabbit model: pre-clinical study applicable in the pediatric surgical setting 164
Donor Cell-Derived Osteopoiesis Originates from a Self-Renewing Stem Cell with a Limited Regenerative Contribution after Transplantation 163
Integrated intErventional bronchoscopy in the treatment of locally adVanced non-small lung cancER with central Malignant airway Obstructions: a multicentric REtrospective study (EVERMORE). 163
Proceedings of the signature series symposium “cellular therapies for orthopaedics and musculoskeletal disease proven and unproven therapies—promise, facts and fantasy,” international society for cellular therapies, montreal, canada, May 2, 2018 161
Isolation and Identification of Cancer Stem-Like Cells in Adenocarcinoma and Squamous Cell Carcinoma of the Lung: A Pilot Study 161
TRAIL delivered by mesenchymal stromal/stem cells counteracts tumor development in orthotopic Ewing sarcoma models 160
Mesenchymal stromal/stem cells markers in the human bone marrow 160
Response to Nature commentary “Clear up this stem-cell mess” 159
Understanding Tumor-Stroma Interplays for Targeted Therapies by Armed Mesenchymal Stromal Progenitors: The Mesenkillers. 159
Transplanted bone marrow mononuclear cells and MSCs impart clinical benefit to children with osteogenesis imperfecta through different mechanisms 158
Part 5: Unproven cell therapies and the commercialization of cell-based products 158
Application of multipotent mesenchymal stromal cells in pediatric patients following allogeneic stem cell transplantation 158
Inhibiting interactions of lysine demethylase LSD1 with Snail/Slug blocks cancer cell invasion. 158
Proteasome inhibitors sensitize colon carcinoma cells to TRAIL-induced apoptosis via enhanced release of Smac/DIABLO from the mitochondria 157
Megakaryocytes promote murine osteoblastic HSC niche expansion and stem cell engraftment after radioablative conditioning 156
Detection of microparticles from human red blood cells by multiparametric flow cytometry 156
GD2 CAR T cells against human glioblastoma 156
Trophoblast stem cells rescue placental defect in SOCS3-deficient mice 154
Carbonic anhydrase IX inhibition is an effective strategy for osteosarcoma treatment 153
Cardiorenal Syndrome Type 1 May Be Immunologically Mediated: A Pilot Evaluation of Monocyte Apoptosis. 152
Effects of a ceramic biomaterial on immune modulatory properties and differentiation potential of human mesenchymal stromal cells of different origin 151
Hematopoietic cells and osteoblasts are derived from a common marrow progenitor after bone marrow transplantation 150
ALDH Expression in Angiosarcoma of the Lung: A Potential Marker of Aggressiveness? 150
Totale 20.324
Categoria #
all - tutte 198.838
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 198.838


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205.763 0 0 0 426 677 1.073 1.244 697 653 282 436 275
2020/20217.895 628 377 655 798 1.004 638 478 734 469 890 792 432
2021/20226.659 365 738 581 348 284 474 400 410 653 525 1.072 809
2022/20237.308 824 784 544 663 742 907 191 654 1.160 136 404 299
2023/20245.124 257 309 365 495 823 502 513 600 154 196 287 623
2024/20251.373 497 226 488 162 0 0 0 0 0 0 0 0
Totale 41.347